Pereira M A, Albuquerque A, Azevedo J G, Torres S, Gomes L, Campos M, Pimenta A
Serviço de Cardiologia, Hospital de São João, Porto.
Rev Port Cardiol. 1991 Mar;10(3):229-35.
To evaluate the value of some indirect reperfusion signs (IRS) as markers of coronary artery patency in patients (PTS) with acute myocardial infarction (AMI) submitted to intravenous (IV) thrombolytic therapy (TT).
Retrospective study, with analysis of the sensibility (S), specificity (SP) and predictive value (PV) of three IRS: 1. Pain and ST resolution in the first three hours; 2. Peak CK in the first 13 hours; 3. accelerated idioventricular rhythm (AIVR) in the first three hours.
Coronary Care Unit (CCU) of the Santo António Hospital and Hemodynamic Laboratory of the S. João Hospital, Oporto.
Sixty seven PTS (mean age 53.4 +/- 10.6 years) with confirmed AMI, 62 male and five female, 34 with anterior and 33 with inferior infarction, TT started in the first three hours of the beginning of symptoms in 34 PTS and from three to six hours in 33 PTS, all submitted to coronary angiography in the hospital setting (7.6 +/- 5.9 days after AMI).
IV administration of 1,500,000 U of streptokinase (SK) in 47 PTS and 30 U of APSAC in 20 PTS, preceded by 200 mg IV prednisolone and oral 100 mg acetilsalicylic acid, and followed by IV heparin therapy. Continuous electrocardiographic monitoring, and serial 12 leads ECG and enzymatic assays (at start and 1, 3, 7, 13 and 25 hours of TT). Analysis of the correlation of the three IRS (isolated and in association) with coronary artery patency (TIMI 2 or 3).
The total patency rate was 79.1%; there was no statistically significant difference with regard to AMI location, time of symptoms onset (0-3 vs 3-6 hours) or thrombolytic agent (SK vs APSAC). The first and second IRS had a high S and a low SP; together S = 79.2%, SP = 64.3% and PV = 89.4%. The third IRS with the first and/or the second one had a low S (about 25%) but SP and PV of 100%. The coronary patency rate of PTS without IRS was always greater than 50%.
The analysed IRS although not very reliable are useful when considered in association. It is possible to assess PTA with high probability of reperfusion if AIVR is present. The absence of IRS does not exclude coronary artery patency. There is still missing more reliable no-invasive reperfusion markers.
评估某些间接再灌注征象(IRS)作为接受静脉溶栓治疗(TT)的急性心肌梗死(AMI)患者冠状动脉通畅标志物的价值。
回顾性研究,分析三种IRS的敏感性(S)、特异性(SP)和预测价值(PV):1. 最初三小时内疼痛和ST段回落;2. 最初13小时内肌酸激酶峰值;3. 最初三小时内加速性室性自主心律(AIVR)。
波尔图圣安东尼奥医院冠心病监护病房(CCU)和圣若昂医院血流动力学实验室。
67例确诊AMI患者(平均年龄53.4±10.6岁),男性62例,女性5例,前壁梗死34例,下壁梗死33例,34例患者在症状出现的最初三小时内开始TT,33例患者在三至六小时内开始TT,所有患者均在医院进行冠状动脉造影(AMI后7.6±5.9天)。
47例患者静脉注射150万单位链激酶(SK),20例患者静脉注射30单位茴香酰化纤溶酶原链激酶激活剂复合物(APSAC),之前静脉注射200毫克泼尼松龙和口服100毫克乙酰水杨酸,之后进行静脉肝素治疗。持续心电图监测,以及系列12导联心电图和酶学检测(TT开始时及开始后1、3、7、13和25小时)。分析三种IRS(单独及联合)与冠状动脉通畅(TIMI 2或3级)的相关性。
总通畅率为79.1%;在AMI部位、症状发作时间(0 - 3小时与3 - 6小时)或溶栓药物(SK与APSAC)方面无统计学显著差异。第一种和第二种IRS具有高敏感性和低特异性;联合时S = 79.2%,SP = 64.3%,PV = 89.4%。第三种IRS与第一种和/或第二种联合时敏感性低(约25%),但特异性和预测价值为100%。无IRS的患者冠状动脉通畅率始终大于50%。
所分析的IRS虽然不太可靠,但联合考虑时有用。如果存在AIVR,则有可能高度评估经皮腔内冠状动脉成形术(PTA)的再灌注情况。无IRS并不排除冠状动脉通畅。仍然缺少更可靠的无创再灌注标志物。